Magnesium in Aneurysmal Subarachnoid Hemorrhage (MASH-II) "MASH-II"

Recruiting

Phase N/A Results N/A

Summary of Purpose

To determine whether magnesium reduces the frequency of poor outcome (death or dependence) in patients admitted within 4 days after aneurysmal subarachnoid hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 March 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • University Medical Centre Utrecht (UMCU) (The Netherlands) The Netherlands Heart Foundation (grant number: 2005B016).

Trial Design

Multi-centre, randomised, double-blind, placebo controlled, parallel group trial.

Contacts

  • Sanne M. Dorhout Mees, MD, Department of Neurology G03.224, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands. Phone +31-30-2508350. Fax +31-30-2522782. E-mail S.M.Dorhoutmees@umcutrecht.nl

    S.M.Dorhoutmees@umcutrecht.nl